Innocan Pharma Stock Technical Analysis
| INNPF Stock | USD 5.73 1.02 21.66% |
As of the 12th of February 2026, InnoCan Pharma retains the Market Risk Adjusted Performance of 0.7272, standard deviation of 8.06, and Risk Adjusted Performance of (0.11). InnoCan Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for twelve technical drivers for InnoCan Pharma, which can be compared to its competitors. Please check out InnoCan Pharma variance and value at risk to decide if InnoCan Pharma is priced fairly, providing market reflects its last-minute price of 5.73 per share. Given that InnoCan Pharma has total risk alpha of (2.14), we strongly advise you to confirm InnoCan Pharma's regular market performance to make sure the company can sustain itself at a future point.
InnoCan Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as InnoCan, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InnoCanInnoCan |
InnoCan Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to InnoCan Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of InnoCan Pharma.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in InnoCan Pharma on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding InnoCan Pharma or generate 0.0% return on investment in InnoCan Pharma over 90 days. InnoCan Pharma is related to or competes with Goodness Growth, SymBio Pharmaceuticals, and RetinalGenix Technologies. InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms comb... More
InnoCan Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure InnoCan Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess InnoCan Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 63.93 | |||
| Value At Risk | (17.38) |
InnoCan Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for InnoCan Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as InnoCan Pharma's standard deviation. In reality, there are many statistical measures that can use InnoCan Pharma historical prices to predict the future InnoCan Pharma's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (2.14) | |||
| Treynor Ratio | 0.7172 |
InnoCan Pharma February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 0.7272 | |||
| Mean Deviation | 3.41 | |||
| Coefficient Of Variation | (681.89) | |||
| Standard Deviation | 8.06 | |||
| Variance | 64.9 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (2.14) | |||
| Treynor Ratio | 0.7172 | |||
| Maximum Drawdown | 63.93 | |||
| Value At Risk | (17.38) | |||
| Skewness | 2.18 | |||
| Kurtosis | 20.85 |
InnoCan Pharma Backtested Returns
InnoCan Pharma holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15 % return per unit of risk over the last 3 months. InnoCan Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out InnoCan Pharma's Risk Adjusted Performance of (0.11), standard deviation of 8.06, and Market Risk Adjusted Performance of 0.7272 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -1.66, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning InnoCan Pharma are expected to decrease by larger amounts. On the other hand, during market turmoil, InnoCan Pharma is expected to outperform it. At this point, InnoCan Pharma has a negative expected return of -1.28%. Please make sure to check out InnoCan Pharma's maximum drawdown, as well as the relationship between the daily balance of power and market facilitation index , to decide if InnoCan Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.52 |
Modest predictability
InnoCan Pharma has modest predictability. Overlapping area represents the amount of predictability between InnoCan Pharma time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of InnoCan Pharma price movement. The serial correlation of 0.52 indicates that about 52.0% of current InnoCan Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.57 |
InnoCan Pharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
InnoCan Pharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for InnoCan Pharma across different markets.
About InnoCan Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of InnoCan Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of InnoCan Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on InnoCan Pharma price pattern first instead of the macroeconomic environment surrounding InnoCan Pharma. By analyzing InnoCan Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of InnoCan Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to InnoCan Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
InnoCan Pharma February 12, 2026 Technical Indicators
Most technical analysis of InnoCan help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for InnoCan from various momentum indicators to cycle indicators. When you analyze InnoCan charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 0.7272 | |||
| Mean Deviation | 3.41 | |||
| Coefficient Of Variation | (681.89) | |||
| Standard Deviation | 8.06 | |||
| Variance | 64.9 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (2.14) | |||
| Treynor Ratio | 0.7172 | |||
| Maximum Drawdown | 63.93 | |||
| Value At Risk | (17.38) | |||
| Skewness | 2.18 | |||
| Kurtosis | 20.85 |
InnoCan Pharma February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as InnoCan stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 95.81 | ||
| Daily Balance Of Power | 1.67 | ||
| Rate Of Daily Change | 1.22 | ||
| Day Median Price | 5.43 | ||
| Day Typical Price | 5.53 | ||
| Price Action Indicator | 0.82 | ||
| Market Facilitation Index | 0.0007 |
Complementary Tools for InnoCan OTC Stock analysis
When running InnoCan Pharma's price analysis, check to measure InnoCan Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnoCan Pharma is operating at the current time. Most of InnoCan Pharma's value examination focuses on studying past and present price action to predict the probability of InnoCan Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnoCan Pharma's price. Additionally, you may evaluate how the addition of InnoCan Pharma to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |